Tardive Dyskinesia Clinical Trial
Official title:
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Prospective study to quantify the prevalence of possible tardive dyskinesia (TD) in outpatient psychiatry practices in the United States (US), as well as to describe the associated disease burden in a cohort of patients with one or more psychiatric disorders and a cumulative lifetime exposure to antipsychotic medication of three months or more.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02840760 -
Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.
|
N/A | |
Completed |
NCT01688037 -
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
|
Phase 2 | |
Completed |
NCT01391390 -
Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
|
N/A | |
Withdrawn |
NCT03254186 -
Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
|
Phase 2/Phase 3 | |
Completed |
NCT02291861 -
Addressing Involuntary Movements in Tardive Dyskinesia
|
Phase 3 | |
Completed |
NCT02274558 -
A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia
|
Phase 3 | |
Completed |
NCT02198794 -
Reducing Involuntary Movements in Participants With Tardive Dyskinesia
|
Phase 3 | |
Completed |
NCT01467089 -
The Assessment of Movement Disorders Utilizing Live Two-Way Video
|
N/A | |
Completed |
NCT04794413 -
Pimavanserin Treatment in TS
|
Early Phase 1 | |
Recruiting |
NCT06011408 -
Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes
|
N/A | |
Recruiting |
NCT05859698 -
Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
|
Phase 4 | |
Active, not recruiting |
NCT02252380 -
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
|
N/A | |
Terminated |
NCT00917293 -
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
|
Phase 2 | |
Completed |
NCT01543321 -
Xenazine in Late Dyskinetic Syndrome With Neuroleptics
|
Phase 3 | |
Completed |
NCT02405091 -
Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia
|
Phase 3 | |
Completed |
NCT03176771 -
Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
|
Phase 2/Phase 3 | |
Terminated |
NCT02524886 -
Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia
|
N/A | |
Completed |
NCT02195700 -
Aim to Reduce Movements in Tardive Dyskinesia
|
Phase 2/Phase 3 | |
Completed |
NCT02736955 -
Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia
|
Phase 3 | |
Completed |
NCT03497013 -
Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia
|
N/A |